Metagenomi, Inc. Common Stock (MGX) — Cash Flow Reinvestment Rate
Metagenomi, Inc. Common Stock (MGX) has a Cash Flow Reinvestment Rate of 0.63x as of December 2022, reinvesting $42.38 Million (capex $3.51 Million plus investments $-38.87 Million) from operating cash flow of $67.73 Million. See how much free cash does Metagenomi, Inc. Common Stock generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Metagenomi, Inc. Common Stock Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for Metagenomi, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see MGX cash flow metrics.
Annual Cash Flow Reinvestment Rate for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year capital reinvestment analysis for Metagenomi, Inc. Common Stock. See MGX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 4.58x | $136.18 Million | $29.72 Million | $13.98 Million | ▲ +43.9% |
| 2021 | 3.18x | $77.22 Million | $24.26 Million | $2.90 Million | — |